Life Flow

Poland
Nowosielce-Gniewosz, Subcarpathia, Poland, 53-125

Company profile

Life Flow company profile

What we do: LifeFlow is a MedTech startup specializing in cardiac diagnostics. It is one of the 2 companies worldwide which have developed a technology enabling non-invasive assessment of the functional significance of coronary artery lesions based on numerical simulations of blood flow using CFD methods (Computational Fluid Dynamics). Market need: Every year 2,5 mln people in Europe are diagnosed with the coronary heart disease (CHD). CHD is the cause of every fifth dead in development countries. Coronary artery disease, a leading cause of CHD, nowadays is diagnosed using Coronary angiography. These procedures are expensive, invasive and risky for the patient. The estimated, yearly market potential for LifeFlow diagnostic is 1 mln services in Europe and 1.25 mln services in the US. Solution: LifeFlow technology iSIL-FFR (in SILico FFR), is a post-processing software run as Software as a Service (SaaS) in the cloud for non-invasive assessment of the functional significance of coronary artery lesions based on a three-dimensional reconstruction of the lumen of the coronary arteries from static CCTA and numerical simulations of blood flow in reconstructed vessels.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2015-01-01, Year

Headquarters

Postal code
53-125
Country code
PL
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Seed / 2015-11-17
Last equity funding
Seed
Investors
1
Founders
3

Founders and investors

Founders

Andrzej KosiorKryspin MirotaWojtek Tarnawski

Investors

LSI (Life Science Innovations Fund)